Pharma Reviews: Intas closing in on Mallinckrodt's US generics business
A successful transaction will give Intas — the largest privately held pharmaceutical company in India with an annual turnover of over $1 billion and a ...
Read more: Intas closing in on Mallinckrodt's US generics business